asked my compounder where the API comes from. long silence.
503B. That is the whole post, but I will justify it. Everything else people worry about in c/t2dglp1 is downstream of it. Titration speed, reflux, the endless dose arguments — most of it resolves if you sort 503B out first, and almost nobody does. I say this having got it wrong for 11 months. My ApoB was the thing…
the Denmark situation is different from the US, different regulations
telehealth costs API source plus compounding markup, total varies
regulatory claims need a citation to the actual rule, not interpretation